Showing 10 of 36 Clinical Trials

• NRG-LU008

  Lung Cancer Accepting Patients

  Phase III Prospective Randomized Trial Of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed By Concurrent Mediastinal Chemoradiation For Locally Advanced Non-Small Cell Lung Cancer

• NSABP B-51

  Breast Cancer Not Accepting Patients

  A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

• PALLAS AFT-05

  Breast Cancer Not Accepting Patients

  PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+)/ Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer

• PATINA AFT-38

  Breast Cancer Not Accepting Patients

• PFO PAS

  Cryptogenic Stroke Not Accepting Patients

• PK Papyrus (HUD)

  Coronary Stent Accepting Patients

  PK Papyrus Humanitarian Use Device

• RTOG-1005

  Breast Cancer Not Accepting Patients

  A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early Stage Breast Cancer

• S1007

  Breast Cancer Not Accepting Patients

  A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or less.

• S1418

  Breast Cancer Not Accepting Patients

  S1418: A Randomized Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with greater than or equal to 1 cm Residual Invasive Cancer or Positive Lymph Nodes After Neoadjuvant Chemotherapy.

• S1931

  Renal Accepting Patients

  Phase III Trial of Immunotherapy-Based Combination Therapy with or without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)